Mesoblast | MSB - Ebitda

Stock Price
2.47
Daily Change
-0.02 -0.80%
Monthly
-10.51%
Yearly
-18.21%
Q1 Forecast
2.48

Mesoblast reported $-17.78M in EBITDA for its fiscal semester ending in June of 2025.





Ebitda Change Date
Avita Medical AUD -21.9M 12.04M Jun/2025
Clinuvel Pharmaceuticals AUD 27.55M 12.65M Jun/2025
Cochlear AUD 292.9M 30.1M Jun/2025
CSL USD 1.96B 1.27B Jun/2025
Pacific Edge NZD -13.97M 332K Sep/2024
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
PYC Therapeutics AUD -24.29M 1.3M Jun/2025
Ramsay Health Care AUD 1.11B 84.1M Jun/2025
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Starpharma Holdings AUD -4.85M 1.73M Dec/2024
Telix Pharmaceuticals AUD 33.24M 6.5M Jun/2025